BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37638816)

  • 21. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
    Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy.
    Turner H; Séguin B; Worley DR; Ehrhart NP; Lafferty MH; Withrow SJ; Selmic LE
    J Am Vet Med Assoc; 2017 Dec; 251(11):1293-1305. PubMed ID: 29154712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?
    Reddy KI; Wafa H; Gaston CL; Grimer RJ; Abudu AT; Jeys LM; Carter SR; Tillman RM
    Bone Joint J; 2015 Jan; 97-B(1):115-20. PubMed ID: 25568424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
    Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
    Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery.
    Bishop AJ; Livingston JA; Araujo DM; Moon BS; Patel S; Wang WL; Lazar AJ; Roland CL; Guadagnolo BA
    Am J Clin Oncol; 2019 Mar; 42(3):238-242. PubMed ID: 30614820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.
    Scully SP; Ghert MA; Zurakowski D; Thompson RC; Gebhardt MC
    J Bone Joint Surg Am; 2002 Jan; 84(1):49-57. PubMed ID: 11792779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
    Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
    Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
    J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.
    Tabone MD; Terrier P; Pacquement H; Brunat-Mentigny M; Schmitt C; Babin-Boilletot A; Mahmoud HH; Kalifa C
    J Clin Oncol; 1999 Sep; 17(9):2789-95. PubMed ID: 10561354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
    Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
    Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
    J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study.
    Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Dhamne C; Blair S; Lam C; Rujkijyanont P; Traivaree C; Photia A; Veerapan P; Puhaindran ME; Oh BLZ; Wang E; Rodriguez-Galindo C
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):631-640. PubMed ID: 35225476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.